Claritas Capital

Claritas Capital is a Nashville-based investment firm with a multi-asset-class mandate spanning private equity, venture, real estate, and structured credit, with a focus on the Southeast US. Healthcare exposure is plausible given Nashville’s status as a major US healthcare-services hub, with the firm’s portfolio likely tilting toward healthcare services, payer-services businesses, and tech-enabled healthcare companies rather than pure clinical AI or biotech. Stage and check sizes vary by vehicle, but venture activity is plausibly seed through Series B with check sizes between $500K and $5M. For healthcare AI founders, Claritas is most relevant if you are a Southeast US-based or Southeast US-deploying healthcare-services or healthcare-software company with revenue, traction, and a credible exit pathway through strategic acquirers in the Nashville healthcare-services ecosystem (HCA, Community Health Systems, LifePoint, and similar). Founders who should approach: healthcare-services-flavored AI companies — RCM, post-acute coordination, employer benefits, payer services, claims automation — with a Southeast operating footprint and a sober capital-efficient story. Founders who should not approach: deep-tech biotech, regulated medical devices, consumer-only digital health, and West Coast-flavored category-creation plays. Claritas’s value-add is the Nashville healthcare-services network — relationships with provider operators, payer leadership, and middle-market healthcare strategics — combined with patient capital and pragmatic governance. Entry path is warm introduction through Nashville healthcare operators, regional bankers, or portfolio CEOs. Their LinkedIn page provides partner contact. Be prepared for a diligence process that emphasizes financial profile, customer concentration, and exit pathway.